Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-06Clinical Trial Update: Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients [Phase 2]
Phase 2 clinical trial investigating WX-0593 in ALK-positive non-small cell lung cancer (NSCLC) patients.
-
CLINICAL_TRIALS trial_result · 2023-04-05Clinical Trial Update: YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations [Phase 3]
A Phase 3 trial comparing YK-029A to platinum-based chemotherapy as first-line treatment for advanced/metastatic NSCLC with EGFR exon 20 ins…
-
CLINICAL_TRIALS trial_result · 2023-04-05Clinical Trial Update: Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial exploring armatinib alone or with SRT for brain metastases in EGFR-mutated non-small cell lung cancer; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-04-05Clinical Trial Update: Efficacy and Safety of PVT-1 Treatment in Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial update evaluating efficacy and safety of PVT-1 treatment in advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-04-05Clinical Trial Update: A Phase Ⅱ Trial of Neoadjuvant Toripalimab Plus Platinum-doublet Chemotherapy in Locally Advanced NSCLC. [Phase 2]
Phase II neoadjuvant trial evaluating toripalimab plus platinum-doublet chemotherapy in locally advanced non-small cell lung cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: Re-Induction After Initial Response With Immune Therapy With Radiotherapy in Lung Cancer [Phase 2]
Phase 2 trial evaluating re-induction with immune therapy plus radiotherapy in stage IV non-small cell lung cancer after initial response.
-
CLINICAL_TRIALS trial_result · 2023-04-03Clinical Trial Update: Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC [Phase 3]
A Phase 3 clinical trial update investigating atezolizumab with carboplatin, paclitaxel, and bevacizumab in NSCLC patients with EGFR mutatio…
-
CLINICAL_TRIALS trial_result · 2023-04-03Clinical Trial Update: Trial Involving Subjects Over 70 Years of Age With Non Small-cell Lung Cancer of Stage IV and Comparing a "Classical" Strategy of Treatment Allocation, With an"Optimized" Strategy Allocating the Same Treatments [Phase 3]
Phase 3 trial comparing a 'classical' treatment allocation strategy versus an 'optimized' strategy for subjects with advanced non-small cell…
-
CLINICAL_TRIALS trial_result · 2023-03-31Clinical Trial Update: Foundation and Clinical About the Expression of PD-1 in Peripheral Blood T Lymphocytes [Phase 2]
Phase 2 clinical trial update examining PD-1 expression in peripheral blood T cells for non-small cell lung cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial evaluating osimertinib in combination with bevacizumab for patients with brain metastases from EGFR-mutant metastatic…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating osimertinib in combination with bevacizumab for EGFR exon 20 insertion metastatic non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Chemotherapy Combines With Bevacizumab and PD-1 Inhibitor in Non-squamous NSCLC [Phase 2]
Phase 2 trial evaluating chemotherapy with bevacizumab and a PD-1 inhibitor in non-squamous non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Phase II Study of Afatinib Plus Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon G719X, S768I, and L861Q Mutation Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase II study investigating afatinib plus bevacizumab for metastatic non-small cell lung cancer with EGFR G719X, S768I, and L861Q mutations…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Mechanism of Response to IMFINZI Neoadjuvant Therapy in Non-small Cell Lung Cancer Patients Based on Multiple-omics Models [Phase 1, Phase 2]
A clinical trial update investigating mechanisms of response to IMFINZI neoadjuvant therapy in non-small cell lung cancer using multiple-omi…
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: AZD9291, an Irreversible EGFR-TKI, in Relapsed EGFR-mutated Non-small Cell Lung Cancer Patients Previously Treated With an EGFR-TKI, Coupled to Extensive Translational Studies [Phase 2]
Phase 2 clinical trial update of AZD9291 (osimertinib) in relapsed EGFR-mutated non-small cell lung cancer after prior EGFR-TKI treatment, w…
-
CLINICAL_TRIALS trial_result · 2023-03-27Clinical Trial Update: Efficacy Study of Osimertinib in Treatment-naïve Patients With EGFR Mutant NSCLC According to TP53 Mutational Status. [Phase 4]
A Phase 4 clinical trial assessing the efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer, stratified by TP53…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung Cancer [Phase 3]
A phase 3 clinical trial comparing bevacizumab plus erlotinib versus erlotinib alone as first-line treatment for EGFR-mutated advanced non-s…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer [Phase 3]
Phase 3 trial evaluating cisplatin in combination with gemcitabine for elderly patients with non-small cell lung cancer (metastatic or stage…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung Cancer [Phase 3]
Phase 3 trial comparing gemcitabine and pemetrexed with or without cisplatin in nonsquamous non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Chemo-immunotherapy Induction Followed by Hypo-radiotherapy in LA-NSCLC(CHIC) [Phase 2]
Phase 2 clinical trial update investigating chemo-immunotherapy induction followed by hypo-radiotherapy in locally advanced non-small cell l…
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901 [Phase 2]
Phase 2 trial evaluating pembrolizumab plus pemetrexed in elderly patients with non-squamous non-small cell lung cancer and PD-L1 < 50%.
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC [Phase 2, Phase 3]
Phase 2/3 trial investigating rofecoxib with prolonged gemcitabine infusion in advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: Study of Polymeric Micellar Paclitaxel, Platinum Combined With Sindilizumab Injection for Advanced Non-squamous NSCLC [Phase 2]
Phase 2 trial update for a combination of polymeric micellar paclitaxel, platinum, and sindilizumab in advanced non-squamous non-small cell …
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: PD-L1 Expression in Lung Cancer [Phase 2]
Phase 2 trial update examining PD-L1 expression in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-03-20Clinical Trial Update: Efficacy of SRT as Salvage Therapy in Patients With Brain Oligo-progression of EGFR-mutant Non-small Cell Lung Cancer After Failure of the Third-generation EGFR-TKIs [Phase 2]
A Phase 2 trial evaluating SRT as salvage therapy for brain oligoprogression in EGFR-mutant non-small cell lung cancer after failure of thir…